fenvalerate has been researched along with Parkinson Disease, Secondary in 1 studies
fenvalerate: synthetic pyrethroid; RN given refers to cpd without isomeric designation; structure
fenvalerate : A carboxylic ester obtained by formal condensation between 2-(4-chlorophenyl)-3-methylbutyric acid and cyano(3-phenoxyphenyl)methanol.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, J | 1 |
| Xia, R | 1 |
| Liu, Z | 1 |
| Shen, J | 1 |
| Gong, X | 1 |
| Hu, Y | 1 |
| Chen, H | 1 |
| Yu, Y | 1 |
| Gao, W | 1 |
| Wang, C | 1 |
| Wang, SL | 1 |
1 other study available for fenvalerate and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Fenvalerate triggers Parkinson-like symptom during zebrafish development through initiation of autophagy and p38 MAPK/mTOR signaling pathway.
Topics: Animals; Autophagy; Dopaminergic Neurons; Humans; Insecticides; MAP Kinase Signaling System; Neuroge | 2020 |